RISKREVEAL
LIVE

Serial Number

98297986

Owner

Razor Genomics, Inc.

Attorney

DAVID R. STEVENS

Filing Date

Dec 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RISKREVEAL Trademark

Serial Number: 98297986

RISKREVEAL is a trademark filed by Razor Genomics, Inc. on December 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Razor Genomics, Inc.

110 10th Avenue, Suite 102, Room 123
Nashville, TN 37203

Entity Type: 03

Trademark Details

Filing Date

December 4, 2023

Registration Date

Not Registered

Published for Opposition

November 26, 2024

Goods & Services

Medical diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical diagnostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Formalin fixed, paraffin embedded (FFPE) diagnostic kits comprised of medical diagnostic reagents and assays for testing of tumor tissue for use in risk segregation and managing disease treatment, namely, cancer

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jul 7, 2026 EX3G
SOU EXTENSION 3 FILED
Jul 7, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 7, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 5, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 5, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 5, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 3, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 2, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 2, 2025 EEXT
ASSIGNED TO EXAMINER
Apr 1, 2025 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 31, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 31, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 31, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 31, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 9, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 9, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 24, 2024 NWOS
NEW APPLICATION ENTERED
Dec 7, 2023 NWAP